Paper42976342PubMed
Digital Augmentation of Glucagon-Like Peptide-1 for Obesity Management: Retrospective Study.
Davey B and 4 others. J Med Internet Res, 2026.
Cite this record
ConductScience Library. Digital Augmentation of Glucagon-Like Peptide-1 for Obesity Management: Retrospective Study. Papers, record 42976342. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42976342
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Digital Augmentation of Glucagon-Like Peptide-1 for Obesity Management: Retrospective Study.
- Journal
- J Med Internet Res
- Year
- 2026
- Publication types
- Journal Article, Observational Study
- Revised in PubMed
- 2026-11-05
Source PubMed
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Glucagon-Like Peptide 1 | Major topic |
| Obesity | Major topic |
| Glucagon-Like Peptides | Major topic |
| Mobile Applications | Major topic |
| Obesity Management | Major topic |
| Humans | |
| Retrospective Studies | |
| Female | |
| Semaglutide | |
| Male | |
| Tirzepatide | |
| Middle Aged | |
| Adult | |
| Weight Loss | |
| Digital Health | |
| Glucagon-Like Peptide-1 Receptor Agonists |
Source PubMed
References59
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 11231746 | Using Internet technology to deliver a behavioral weight loss program. | JAMA | 2001 | https://conductscience.org/library/papers/11231746 | PubMed |
| 2 | 19757444 | Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples. | Stat Med | 2009 | https://conductscience.org/library/papers/19757444 | PubMed |
| 3 | 28941113 | The efficacy of smartphone-based mental health interventions for depressive symptoms: a meta-analysis of randomized controlled trials. | World Psychiatry | 2017 | https://conductscience.org/library/papers/28941113 | PubMed |
| 4 | 38717042 | Real-world persistence and adherence to glucagon-like peptide-1 receptor agonists among obese commercially insured adults without diabetes. | J Manag Care Spec Pharm | 2024 | https://conductscience.org/library/papers/38717042 | PubMed |
| 5 | 26916363 | Effects of Moderate and Subsequent Progressive Weight Loss on Metabolic Function and Adipose Tissue Biology in Humans with Obesity. | Cell Metab | 2016 | https://conductscience.org/library/papers/26916363 | PubMed |
| 6 | 40146920 | Glucagon-Like Peptide-1 Receptor Agonists Combined With Personalized Digital Health Care for the Treatment of Metabolic Syndrome in Adults With Obesity: Retrospective Observational Study. | Interact J Med Res | 2025 | https://conductscience.org/library/papers/40146920 | PubMed |
| 7 | 35664248 | Adherence to mobile-app-based dietary self-monitoring-Impact on weight loss in adults. | Obes Sci Pract | 2022 | https://conductscience.org/library/papers/35664248 | PubMed |
| 8 | 15350854 | Social cognitive theory of posttraumatic recovery: the role of perceived self-efficacy. | Behav Res Ther | 2004 | https://conductscience.org/library/papers/15350854 | PubMed |
| 9 | 35925469 | The Potential Role of Digital Health in Obesity Care. | Adv Ther | 2022 | https://conductscience.org/library/papers/35925469 | PubMed |
| 10 | 33755728 | Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial. | JAMA | 2021 | https://conductscience.org/library/papers/33755728 | PubMed |
| 11 | 40434299 | A Remotely Delivered GLP-1RA-Supported Specialist Weight Management Program in Adults Living With Obesity: Retrospective Service Evaluation. | JMIR Form Res | 2025 | https://conductscience.org/library/papers/40434299 | PubMed |
| 12 | 37445623 | Emerging Role of GLP-1 Agonists in Obesity: A Comprehensive Review of Randomised Controlled Trials. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37445623 | PubMed |
| 13 | 16002825 | Long-term weight loss maintenance. | Am J Clin Nutr | 2005 | https://conductscience.org/library/papers/16002825 | PubMed |
| 14 | 29113089 | Predicting Physical Activity and Healthy Nutrition Behaviors Using Social Cognitive Theory: Cross-Sectional Survey among Undergraduate Students in Chongqing, China. | Int J Environ Res Public Health | 2017 | https://conductscience.org/library/papers/29113089 | PubMed |
| 15 | 35512849 | The Antiobesity Effect and Safety of GLP-1 Receptor Agonist in Overweight/Obese Patients Without Diabetes: A Systematic Review and Meta-Analysis. | Horm Metab Res | 2022 | https://conductscience.org/library/papers/35512849 | PubMed |
| 16 | 42070563 | Ultra-processed food policy must regulate the screen as well as the street. | Lancet | 2026 | https://conductscience.org/library/papers/42070563 | PubMed |
| 17 | 27054302 | Evidence that implementation intentions can overcome the effects of smoking habits. | Health Psychol | 2016 | https://conductscience.org/library/papers/27054302 | PubMed |
| 18 | 35663278 | Engagement in Digital Health App-Based Prevention Programs Is Associated With Weight Loss Among Adults Age 65. | Front Digit Health | 2022 | https://conductscience.org/library/papers/35663278 | PubMed |
| 19 | 40956256 | American Association of Clinical Endocrinology Consensus Statement: Algorithm for the Evaluation and Treatment of Adults with Obesity/Adiposity-Based Chronic Disease - 2025 Update. | Endocr Pract | 2025 | https://conductscience.org/library/papers/40956256 | PubMed |
| 20 | 33624440 | Self-Monitoring via Digital Health in Weight Loss Interventions: A Systematic Review Among Adults with Overweight or Obesity. | Obesity (Silver Spring) | 2021 | https://conductscience.org/library/papers/33624440 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42976342
GET https://conductscience.org/api/papers/v1/42976342/references?page=2